ANGO Financial Facts
Sales and marketing: 18.52MOperating income: 58K
See Full Income Statement
Deferred income taxes: 6.75M
Total cash, cash equivalents and marketable securities: 18.78M
See Full Balance Sheet
Earnings History for AngioDynamics (ANGO)
|
Expand Research on ANGO
| Next EPS Date | 7/11/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -10.3% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/12  |
 |
Q313 | $0.09 | $0.08 | +$0.01 | $51.6M | $51.34M | N/A / N/A | = | -13.5% | Details |
| 4/8/13 |
|
Q313 | $0.05 | $0.05 | $0.00 | $81.6M | $81.7M | N/A / N/A | = | +0.8% | Details |
| 1/3/13 |
|
Q213 | $0.10 | $0.09 | +$0.01 | $87M | $87.4M | N/A / N/A | = | -5.4% | Details |
| 10/8/12 |
|
Q113 | $0.10 | $0.09 | +$0.01 | $83.4M | $84.35M | N/A / N/A | = | -16.5% | Details |
| 7/12/12 |
|
Q412 | $0.10 | $0.09 | +$0.01 | $57.7M | $52.97M | N/A / N/A | = | -5.9% | Details |
| 1/5/12 |
|
Q212 | $0.13 | $0.12 | +$0.01 | $53.4M | $56.26M | N/A / N/A | = | -27.4% | Details |
| 10/6/11 |
|
Q112 | $0.08 | $0.08 | $0.00 | $54.4M | $53.86M | N/A / N/A | = | -24.5% | Details |
| 7/14/11 |
|
Q411 | -$0.03 | $0.10 | -$0.13 | $56.4M | $56.96M | N/A / N/A | = | -24.9% | Details |
